MedTrace Logo

Monitoring Pre-exposure Prophylaxis for Young Adult Women

NCT02915367 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 348

Last updated 2023-05-31

Study results available
· View outcomes & findings →

Summary

Next generation real-time monitoring for PrEP adherence in young Kenyan women

Conditions

Interventions

BEHAVIORAL

SMS Reminders

Participants will receive daily reminders, with content and timing of their choosing, regarding their PrEP use. Participants will have the choice to later receive SMS reminders only when they forget to take their dose (as indicated by real-time adherence monitoring via WisePill).

Sponsors & Collaborators

  • University of Washington

    collaborator OTHER

  • Kenya Medical Research Institute

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Jessica Haberer, MD, MS · Massachussetts General Hospital

  • Jared Baeten, MD, PhD · University of Washington

  • Nelly Mugo · Kenya Medical Research Institute

  • Elizabeth Bukusi · Kenya Medical Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
24 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-21
Primary Completion
2020-03-20
Completion
2020-04-30

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02915367 on ClinicalTrials.gov